Chief Business Strategy Officer
VALEANT Pharmaceuticals International. Inc.
Scott Hirsch joined in August of 2016 as Senior Vice President-Business Strategy and assumed the role of Chief Business Strategy Officer in June 2017. Scott was previously a Portfolio and Risk Manager at Citadel, Surveyor Capital. Prior to Citadel, Scott was in the investment banking group of Credit Suisse as the Lead Equity Research Analyst covering Specialty Pharmaceutical and Global Generics companies. Scott also has five years of experience in venture capital operating roles at JP Morgan Partners and Morgan Stanley Ventures portfolio companies. Scott holds an MBA in Healthcare Management and Finance from Wharton and BFA from Rhode Island School of Design.